Preference for rizatriptan 10-mg wafer versus eletriptan 40-mg tablet for acute treatment of migraine

被引：0
|
作者：
Lainez, MJA
Evers, S
Kinge, E
Allais, G
Allen, C
Rao, NA
Rachid, M
Lis, K
机构：
[1] Univ Valencia, Hosp Clin, Valencia, Spain
[2] Univ Munster, D-4400 Munster, Germany
[3] Sanvika Neurol Serv, Sanvidka, Norway
[4] Univ Turin, I-10124 Turin, Italy
来源：
CEPHALALGIA | 2005年 / 25卷 / 10期
关键词：
rizatriptan wafer; eletriptan; patient preference;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：923 / 924
页数：2
相关论文
共 50 条
  • [1] Preference for rizatriptan 10-mg wafer versus eletriptan 40-mg tablet for acute treatment of migraine
    Lainez, MJ
    Evers, S
    Allais, G
    Kinge, E
    Allen, C
    Rao, N
    Massaad, R
    Lis, K
    HEADACHE, 2005, 45 (06): : 807 - 808
  • [2] Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine
    Láinez, MJA
    Evers, S
    Kinge, E
    Allais, G
    Allen, C
    Rao, NA
    Massaad, R
    Lis, K
    CEPHALALGIA, 2006, 26 (03) : 246 - 256
  • [3] Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine
    Pascual, J
    Bussone, G
    Hernandez, JF
    Allen, C
    Vrijens, F
    Patel, K
    EUROPEAN NEUROLOGY, 2001, 45 (04) : 275 - 283
  • [4] Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine
    Loder, E
    Brandes, JL
    Silberstein, S
    Skobieranda, F
    Bohidar, N
    Wang, LX
    Boyle, D
    Kolodny, A
    Guerra, F
    Santanello, N
    Johnson-Pratt, L
    HEADACHE, 2001, 41 (08): : 745 - 753
  • [5] Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine:: Analysis of return to function and patient preference
    Pascual, J
    García-Moncó, C
    Roig, C
    Izquierdo, AY
    López-Gil, A
    HEADACHE, 2005, 45 (09): : 1140 - 1150
  • [6] Determinants of patient preference for either rizatriptan orally disintegrating tablet (ODT) 10 mg or sumatriptan tablet 50 mg for the acute treatment of migraine
    Brandes, JL
    Loder, E
    Boyle, D
    Kolodny, A
    Bohidar, N
    Santanello, N
    Wang, LX
    Johnson-Pratt, L
    NEUROLOGY, 2001, 56 (08) : A359 - A359
  • [7] Rizatriptan 10-mg ODT for Early Treatment of Migraine and Impact of Migraine Education on Treatment Response
    Cady, Roger K.
    Martin, Vincent T.
    Geraud, Gilles
    Rodgers, Anthony
    Zhang, Ying
    Ho, Andrew P.
    Hustad, Carolyn M.
    Ho, Tony W.
    Connor, Kathryn M.
    Ramsey, Karen E.
    HEADACHE, 2009, 49 (05): : 687 - 696
  • [8] A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
    Carl Dahlöf
    Martin Jones
    Kim Davis
    Jane Loftus
    Reijo Salonen
    The Journal of Headache and Pain, 2004, 5 (2) : 115 - 122
  • [9] PLASMA-LEVELS OF CLOBAZAM AFTER 10-MG, 20-MG, AND 40-MG TABLET DOSES IN HEALTHY-SUBJECTS
    VALLNER, JJ
    KOTZAN, JA
    STEWART, JT
    HONIGBERG, IL
    NEEDHAM, TE
    BROWN, WJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (07): : 444 - 451
  • [10] The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg
    Diener, HC
    Ryan, R
    Sun, W
    Hettiarachchi, J
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (02) : 125 - 134
12345